Market Capitalization (Millions $) |
33 |
Shares
Outstanding (Millions) |
15 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-81 |
Cash Flow (TTM) (Millions $) |
5 |
Capital Exp. (TTM) (Millions $) |
0 |
Leap Therapeutics Inc
Leap Therapeutics Inc. is a biopharmaceutical company that focuses on the development and commercialization of immuno-oncology drugs. The company's primary goal is to discover and develop targeted therapies that have the potential to improve patient outcomes in cancers that are difficult to treat or have limited treatment options. Leap Therapeutics is known for its approach of combining therapies that target multiple pathways involved in cancer growth and survival. The company has a diverse pipeline of investigational drugs, including antibody-based therapies and combination therapies. Leap Therapeutics is headquartered in Cambridge, Massachusetts.
Company Address: 47 Thorndike Street Cambridge 2141 MA
Company Phone Number: 714-0360 Stock Exchange / Ticker: NASDAQ LPTX
LPTX is expected to report next financial results on March 23, 2024. |
|
|